Managing data to improve cancer treatment resistance
Coordinating and Data Management Center for Acquired Resistance to Therapy Network
This study is working to help people with cancer whose treatments aren't working by bringing together researchers to share important information and find better ways to treat these patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-11010061 on NIH RePORTER |
What this research studies
This research focuses on coordinating and managing data related to cancer treatment resistance through a network called ARTNet. By integrating resources and fostering collaboration among researchers, the project aims to develop new strategies to overcome challenges faced by patients whose cancers do not respond to standard therapies. The approach includes creating a centralized infrastructure for data sharing and ensuring that the data collected is reliable and reproducible. Patients may benefit from improved treatment options as the findings from this research are translated into clinical practice.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancers that have shown resistance to standard treatment options.
Not a fit: Patients with cancers that are responsive to current therapies may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments for patients who experience resistance to current therapies.
How similar studies have performed: Previous research initiatives focused on cancer treatment resistance have shown promise, indicating that collaborative data management can lead to significant advancements in treatment strategies.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.